Nuclear factor Kappa B mediates interleukin-8 production in eosinophils

International Archives of Allergy and Immunology

Volumn 120, Issue 3, 1999, Pages 230-236

  Yamashita, Naomi ^a   Koizumi, Hirotaka ^b   Yamashita, Naohide ^c   Murata, Machiko ^a   Mano, Kenji ^a   Ohta, Ken ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Eosinophil; GM CSF; IL 8; NF B; TNF

Indexed keywords

ACETYLCYSTEINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0032759368     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024272     Document Type: Article

References (32)

1. Gleich GJ, Adolphson CR, Leiferman KM: Eosinophils; in: Gallin JI et al (eds): Inflammation ed 2. New York, Raven Press, 1992, pp 663-700.
2. Kay AB: Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
3. Frew AJ, Kay AB: Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin Immunol 1990;85:533-539.
4. Broide DH, Paine MM, Firestein GS: Eosinophils express interleukin 5 and granulocyte-macrophage-colony-stimulating factor mRNA at the sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-1424.
5. Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham S: Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of translated product. J Immunol 1995;155:4939-4947.
6. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, Dvorak AM, Weller PF, Galli SJ: Human eosinophils can express the cytokines tumor necrosis factor-α and macrophage inflammatory protein 1α. J. Clin Invest 1993;91:2673-2684.
7. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M: Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179:703-708.
8. Miyamasu M, Hirai K, Takahasi Y, Iida M, Yamaguchi M, Koshino T, Takaishi T, Morita Y, Ohta K, Kasahara T, Ito K: Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995;154:1339-1349.
9. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW, Kornfeld H, Center DM, Weller PF: Human eosinophil elaborate the lymphocyte chemoaltractants. IL-16 (lymphocyte chemoattraclant factor) and RANTES. J Immunol 1996;156:2566-2570.
10. Nakajima H, Gleich GJ, Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996;156:4859-4866.
11. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ: Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 1995;154:4749-4758.
12. Yousefi S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser KS: IL-8 expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 1995;154:5481-5490.
13. Pozdrak K, Stafford S, Alam R: The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J Immunol 1995;155:397-402.
14. Pozdrak K, Schreber DS, Forsythe P, Justement L, Alam R: The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of Lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995;181:1827-1834.
15. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU: Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996;183:1407-1414.
16. Bauerle PA, Henkel T: Function and activation of NF-xB in the immune system. Annu Rev Immunol 1994;12:141-179.
17. Druker BJ, Neumann M, Okuda K, Franza BR, Griffin JD: Rel is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils. J Biol Chem 1994;269:5387-5390.
18. Finco TS, Baldwin AS: Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis. Immunity 1995;3:263-272.
19. DiDobato JA, Mercurio F, Karin M: Phosphorylation of Iκ-Bα precedes but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 1995;15:1302-1311.
20. Lee DH, Goldberg AL: Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 1996;271:27280-27284.
21. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Manialis T, Collins T: The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1996;2:493-506.
22. Clifton DR, Goss RA, Sahni SK, van Antwerp D, Baggs RB, Marder VJ, Silverman DJ, Sporn LA: NF-kappa B-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection. Proc Natl Acad Sci USA 1998;95:4646-4651.
23. Roederer M, Staal FJT, Raju PA, Ela SW, Hezenberg LA: Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci LSA 1990;87:4884-4888.
24. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kinkade RL, Tocci MJ, O'Keefe SJ, O'Neill EA: Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J 1994;13:861-870.
25. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding protein with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
26. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines. J Biol Chem 1990;265:21128-21133.
27. McDonald PP, Bald A, Cassatella MA: Activation of NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 1997;89:3421-3433.
28. Browing DD, Pan ZK, Prossnilz ER, Ye RD: Cell-type-and developmental stage-specific activation of NF-κB by fMet-Leu-Phe in myeloid cells. J Biol Chem 1997;272:7995-8001.
29. Tomioka K, MacGlashan DW, Lichtenstein LM, Bocher BS, Schleimer RP: GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. J Immunol 1993;151:4989-4997.
30. Bates ME, Bertics PJ, Calhoun WJ, Busse WW: Increased protein kinase C activity in low density eosinophils. J Immunol 1993;150:4486-4493.
31. Furuke K, Shiraishi M, Mostowsko HS, Bloom ET: Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J Immunol 1999;162:1988-1993.
32. Galter D, Mihm S, Droge W: Distinct effects of glutathione disulphide on nuclear transcription factor κB and the activator protein-1. Eur J Biochem 1994,221:639-648.